Literature DB >> 11641304

Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.

A K Banes1, S W Watts.   

Abstract

5-Hydroxytryptamine(1B) (5-HT(1B)) receptors have been implicated in mediating arterial contraction to 5-HT. Additionally, the 5-HT(1B) receptor has been reported to be "unmasked" by depolarizing stimuli. We hypothesized that 5-HT(1B) receptors in arteries from hypertensive animals, arteries reported to have a depolarized resting membrane potential in smooth muscle cells, are unmasked and participate in the supersensitivity observed to 5-HT in hypertension. We used the isolated tissue bath apparatus and examined the response of superior mesenteric arteries from normotensive sham and hypertensive deoxycorticosterone acetate (DOCA)-salt rats. The 5-HT(1B) agonists CP93129 and sumatriptan (10(-9) to 10(-5) mol/L) caused a maximal contraction (50+/-12% of phenylephrine [10(-5) mol/L] contraction) in arteries from DOCA-salt rats; no contraction was observed in arteries from normotensive rats. The 5-HT(1B) receptor antagonist GR55562 (100 nmol/L) inhibited both the 5-HT- (4-fold rightward shift) and CP93129-induced (11-fold rightward shift) contractions in mesenteric arteries from hypertensive DOCA-salt rats. In other experiments, arteries from normotensive rats were incubated with 15 mmol/L KCl, as a depolarizing stimulus, and then exposed to 5-HT and CP93129. In the presence of KCl, a small leftward shift to 5-HT was observed. However, the presence of a depolarizing stimulus was unable to produce changes in the 5-HT maximal response to resemble that of arteries from DOCA-salt rats, nor was contraction to CP93129 observed. These data support the conclusions that 5-HT(1B) receptors mediate contraction in mesenteric arteries from hypertensive rats and that this enhanced response to 5-HT is not due to membrane depolarization alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641304     DOI: 10.1161/hy1001.091779

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Serotonin receptors in rat jugular vein: presence and involvement in the contraction.

Authors:  A Elizabeth Linder; Geri L Gaskell; Theodora Szasz; Janice M Thompson; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2010-04-08       Impact factor: 4.030

2.  Mechanisms involved in the regulation of bovine pulmonary vascular tone by the 5-HT1B receptor.

Authors:  C McKenzie; V R Alapati; A MacDonald; A M Shaw
Journal:  Br J Pharmacol       Date:  2009-12-03       Impact factor: 8.739

3.  5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.

Authors:  Robert Patrick Davis; Jill Pattison; Janice M Thompson; Ruslan Tiniakov; Karie E Scrogin; Stephanie W Watts
Journal:  BMC Pharmacol       Date:  2012-05-06

4.  Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells.

Authors:  A K Banes; R D Loberg; F C Brosius; S W Watts
Journal:  BMC Pharmacol       Date:  2001-10-08

5.  5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.

Authors:  Peter M Nelson; Jeremy S Harrod; Kathryn G Lamping
Journal:  Exp Diabetes Res       Date:  2012-12-30

6.  Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.

Authors:  Amy K L Banes; Stephanie W Watts
Journal:  BMC Pharmacol       Date:  2003-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.